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On most dairy farms teat dips are applied to the teats of cows either before or after milking in
order to prevent pathogens from gaining access to the mammary gland via the teat canal. In the
present experiments, a natural teat dip was developed using a fermentate containing the live
bacterium Lactococcus lactis DPC 3251. This bacterium produces lacticin 3147, a two-
component lantibiotic which was previously shown to effectively kill Gram-positive mastitis
pathogens. Lacticin 3147 activity in the fermentate was retained at 53% of its original level
following storage for 3 weeks at 4 8C. In the initial experiments in vitro, 105 colony-forming
units/ml (cfu/ml) of either Staphylococcus aureus, Streptococcus dysgalactiae or Streptococcus
uberis were introduced into the lacticin-containing fermentate. Neither Staph. aureus nor Str.
dysgalactiae could be detected after 30 min or 15 min, respectively, while Str. uberis was
reduced approximately 100-fold after 15 min. Following these trials, preliminary experiments
were performed in vivo on teats of lactating dairy cows. In these experiments, teats were coated
with each of the challenge organisms and then dipped with the lacticin-containing fermented
teat dip. Following a dip contact time of 10 min, staphylococci were reduced by 80% when
compared with the undipped control teat. Streptococcal challenges were reduced by 97% for
Str. dysgalactiae and by 90% for Str. uberis. These trials showed that the teat dip is able to
reduce mastitis pathogens on the teats of lactating cows.
Keywords: Mastitis prevention, teat dip, non-chemical, natural.
Mastitis is the most prevalent and costly disease in dairy
herds, where it is associated with high somatic cell count
(SCC) and decreased milk production. While many studies
have tried to calculate economic losses caused by mastitis,
the conclusions vary widely, as reviewed by Halasa et al.
(2007). A study using national US data from 1996 found
that the decrease in milk production associated with
high bulk milk SCC caused a total loss of up to $810±480
million to the US economy when consumer supply and
demand were taken into account (Losinger, 2005). In the
UK, the annual value of output losses or resource wastage
due to mastitis was estimated to have a direct cost of
£121 million (Bennett et al. 1999). The same study also
estimated annual treatment costs at an average of £61.5
million.
With respect to teat disinfection, teat dipping plays a
crucial role in protection against invading mastitis patho-
gens and consists of treating teats pre- and/or post milking.
It has been estimated that the implementation of teat
dipping costs £1.40 per cow per year. The same study
calculated that herds using three different preventive
measures for mastitis, including teat dipping, could save
an average of £35 per cow per year on disease costs,
which would be a yearly saving of £3500 in a cow herd
averaging 100 animals (Yalcin et al. 1999). Teat dips
commonly contain diluted disinfectants, teat-skin con-
ditioners or emollients as well as surfactants (Pankey et al.
1984). The antibacterial active ingredients used in teat dips
are diluted disinfectants such as iodine or chlorhexidine.
Use of a post-milking teat dip containing 1% iodine led to
residues of 336 mg of iodine/l of milk marking a significant
rise when compared with the corresponding value of
292 mg/l resulting from using 0.1% iodine in dips (Galton*For correspondence; e-mail : paul.ross@teagasc.ie
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et al. 1986). In the 1970s concerns were raised in the USA
over high iodine residues in foods, as some daily intakes
exceeded the ‘safe-levels’ set by the National Research
Council, as found in surveys by Vanderveen (1979). High
iodine levels in milk and dairy products were suggested to
be the major source of dietary iodine intake of the US
population and the percentage of iodine provided by dairy
products for adults and young children was 38–56% and
56–85%, respectively (Park et al. 1981). Use of iodine
products, through either feed supplements or disinfectant
usage in the dairy was subsequently monitored carefully in
dairy herds and has fallen since the 1980s (Pennington
et al. 1989). In recent years, further controversy over iod-
ine residues arose when dermatologists linked the levels of
iodine in dairy products to the development of teenage
acne, with some clinicians advising their acne-affected
patients to avoid the intake of dairy products (Arbesman,
2005; Danby, 2007). Consequently, there is a need to
develop more natural antimicrobials as alternatives for
incorporation into teat dips.
To date, little research has been undertaken to develop
alternative formulations that would reduce the risk of
disinfectant residues in milk and few attempts have been
made to replace chemical teat dips with more ‘natural ’
substances. Previously, an alternative commercial teat dip
containing the bacteriocin nisin was investigated (Sears
et al. 1992; Serieys & Poutrel, 1996). Additionally, exper-
imental teat dips made from a Lactobacillus acidophilus
preparation, from a sour milk product and a teat dip based
on an Aloe Vera gel have all been examined (Oliver &
Mitchell, 1985; Koskinen et al. 1996; Leon et al. 2004).
The rate of new infections was insignificant compared with
the diverse control groups (in most trials iodine-dipped
control groups were included).
Lc. lactis DPC 3147 was originally isolated from an
Irish kefir grain (Rea & Cogan, 1994) and produces the
bacteriocin lacticin 3147. Bacteriocins are peptides pro-
duced by many bacteria for the purpose of destroying their
competitors. Lacticin 3147 is a two-component bacter-
iocin classified as a lantibiotic (Class I bacteriocins) owing
to its unusual lanthionine and b-methyllanthionine groups
which result from post-translational modifications. These
unusual groups assist the bacteriocin in forming a certain
three-dimensional structure which is necessary for its
binding to lipid II, a general cell wall component in Gram-
positive bacteria. The binding of lacticin 3147 to lipid II
leads to potassium leakage to the extracellular space, dis-
sipating the membrane potential, and is followed by cell
apoptosis (McAuliffe et al. 1998; Sit & Vederas, 2008).
Lacticin 3147 is active against a wide range of Gram-
positive bacteria including mastitic pathogens such as
Staph. aureus and Str. dysgalactiae (Ryan et al. 1998). In
previous trials, we showed that incorporation of lacticin
3147 into teat seals improved the protection of animals
against both these organisms (Ryan et al. 1999; Twomey
et al. 2000; Crispie et al. 2005). Subsequent trials have
shown that preparations of the live producing culture
were as effective as commonly used antibiotics for the
treatment of intramammary infections (Crispie et al. 2008;
Klostermann et al. 2008). In the present study, we eval-
uated the ability of a milk-based lacticin-containing fer-
mentate to eliminate the mastitis pathogens Str. uberis,
Str. dysgalactiae and Staph. aureus both in vitro and in
vivo on the teat surface. Staph. aureus and Str. dysga-
lactiae are predominant udder specific pathogens es-
pecially in Northern European countries (Barrett et al.
2005; Persson Waller et al. 2009) and the incidence rates
of mastitis caused by such specific pathogens can be sig-
nificantly reduced by the use of teat dipping (Whist et al.
2007). Str. uberis belongs to the group of environmental
pathogens and is another important Gram-positive mastitis
pathogen which can enter the teat canal after milking
when the closure of the teat orifice is not yet established
and the teat end is contaminated. The aim of the present
study was to examine the bactericidal activity of a lacticin-
containing fermentate against three important mastitis
pathogens as a basis for the development of an effective
teat dip in the future.
Materials and Methods
Bacterial strains
All bacterial strains were either selected from the culture
collection at the Moorepark Food Research Centre,
Teagasc, Moorepark, Fermoy, Co. Cork, Ireland or from
the Bacteria Collection of the Laboratorium voor Micro-
biologie, Universiteit Gent, Belgium (Table 1). The lacto-
coccal strains used in the study were Lc. lactis DPC 3147,
the original strain found to produce the bacteriocin lacticin
3147 and Lc. lactis DPC 3251, another isolate which natu-
rally overproduces the bacteriocin. Lc. lactis DPC 5399, a
derivative of Lc. lactis DPC 3147 which does not contain
the lacticin 3147-encoding plasmid pMRC01, was used
as a lacticin negative control (Bac–). Lc. lactis subsp. cre-
moris HP was used as a lacticin 3147-sensitive indicator
strain. All lactococcal strains were maintained on M17
Agar or Broth (Becton Dickinson and Company, Sparks
MD, USA) supplemented with 0.5% (w/v) Lactose (LM17
Agar and LM17 Broth). The lactococcal strains were grown
overnight at 30 8C.
The mastitis pathogen Staph. aureus DPC 5246 was
isolated from a naturally occurring mastitis case and was
used in previous studies as a challenge organism (Twomey
et al. 2000; Crispie et al. 2005). Str. uberis Diernhofer
1932 and Str. dysgalactiae M were also isolates from
mastitic milk and the latter was used as a challenge strain
in experiments both in vivo and in vitro (Ryan et al. 1999).
All mastitis pathogens were routinely grown in TSB
(Tryptic Soy Broth, B.D. and Co., 38800 Le Pont de Claix,
France) and on Blood Agar Base No. 2 (Merck, Darmstadt,
Germany) supplemented with 0.1% aesculin (w/v, Sigma
Chemical Company, St. Louis MO, USA) and 5–7% (v/v)
whole calf blood (Aesculin Blood Agar, ABA) (IDF, 1981).
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Staphylococci were enumerated on Mannitol Salt Agar
(Merck, Darmstadt, Germany) while streptococci were
grown on Modified Edwards Medium (Oxoid Ltd.,
Hampshire, England) supplemented with 5–7% (v/v)
whole calf blood (IDF, 1981).
Preparation of the teat dip
The teat dip was prepared by growing Lc. lactis DPC 3251
in 10% (w/v) reconstituted skim milk (10% RSM). An
overnight broth culture of the above strain was used to
inoculate 10% RSM and was subsequently grown for 20 h
at 30 8C. The resulting fermentate was then stored at 4 8C
and used as the 3251 teat dip in bactericidal assays and in
experiments in vivo. For the experiments in vitro, a control
fermentate produced by the bacteriocin negative strain Lc.
lactis DPC 5399 was prepared using identical conditions
to the 3251 fermentate. The fermentate of the strain Lc.
lactis DPC 5399 (Bac– fermentate) was chosen because it
is a bacteriocin-negative derivative of the original lacticin
producer Lc. lactis DPC 3147. The pH and the consistency
of the 5399 fermentate were similar to fermentates pro-
duced by the lacticin-overproducing strain Lc. lactis DPC
3251. Both dips were always used within 24 h of pro-
duction.
Lacticin production and storage stability
To assess the storage stability of the bacteriocin in the
Lc. lactis 3251-fermentate at 4 8C, the lacticin activity of a
3251 fermentate, prepared in duplicate, was assayed over
a 3-week period on days 1, 4, 7, 14 and 21. Bacteriocin
activity was measured by an agar well diffusion assay, with
the lacticin 3147-sensitive strain Lc. lactis subspecies cre-
moris HP (Table 1) as the indicator strain. Activity was
measured and expressed as arbitrary units (AU/ml) as de-
scribed by Ryan et al. (1996).
Preparation of challenge bacteria for bactericidal assays
and teat challenges
The challenge bacteria were prepared by inoculating
overnight cultures of Staph. aureus DPC 5246, Str. uberis
Diernhofer 1932 or Str. dysgalactiae M to 1% (v/v) in TSB
and incubating at 37 8C for 16 h. Resulting cultures were
then diluted to a concentration of 105 cfu/ml using TSB
and these dilutions were immediately used as the chal-
lenge in bactericidal assays. Initially, challenge con-
centrations of 105 cfu/ml were also used for experiments in
vivo. To ensure sufficient recoveries to allow accurate as-
sessment of effectiveness for experiments in vivo, the con-
centration of challenge organisms had to be increased to
>107 cfu/ml.
Bactericidal assays measuring the effect of teat dips on
Gram-positive mastitis pathogens
The teat dip was assessed for its ability to kill Gram-
positive mastitis pathogens in vitro. The Bac– fermentate
served as the control dip. In each assay, 1 ml of the diluted
challenge pathogen was mixed with 10 ml of the teat dip.
Immediately after the addition of the challenge to the dip
solution, dips were mixed thoroughly. An aliquot of the
challenge strain was taken immediately (time zero, T0) for
viability counts and the mixture of teat dip and challenge
pathogen was incubated at 37 8C, similarly to experiments
by Koskinen et al. (1996). Ryan et al. (1998) previously
showed that lacticin 3147 was generally more potent
against streptococci than staphylococci and thus, as sta-
phylococcal challenges were expected to be more resilient
than streptococci, aliquots in such challenges were taken
after 30, 60, 120 and 180 min (T30, T60, T120 and T180). To
examine expectedly quicker changes, aliquots for strepto-
coccal challenges were taken after 15, 30, 60 and 120 min
(T15, T30, T60 and T120). Each aliquot was immediately
diluted and 100 ml of each dilution as well as 100 ml of the
original aliquot were plated in duplicate using standard
microbiological procedures as described by Twomey et al.
(2000). Plates were incubated overnight at 37 8C and
viable challenge pathogens were counted. The detection
of pathogen activity was very sensitive and pathogens
o10 cfu/ml could be detected. If no growth was detected
on any of the plates (numbers of pathogens <10 cfu/ml)
then a value of zero was applied (Twomey et al. 2000),
represented as 0 log10 cfu/ml (Fig. 3).
Table 1 Summary of bacterial strains
Strain Description Source or Reference
Lactococci
Lc. lactis DPC 3251 Natural overproducer of lacticin 3147 MFRC†
Lc. lactis DPC 5399 Lacticin 3147 negative strain MFRC
Lc. lactis subsp. cremoris HP Indicator strain, sensitive to lacticin 3147 MFRC
Staphylococci
Staph. aureus DPC 5246 Bovine mastitis clinical isolate MFRC
Streptococci
Str. uberis Diernhofer 1932AL Bovine, mastitis milk BCCMTM/LMG‡
Str. dysgalactiae subsp. dysgalactiae M Bovine mastitis clinical isolate MFRC
† Moorepark Food Research Centre
‡ Bacteria Collection of the Laboratorium voor Microbiologie, Universiteit Gent, Belgium
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Selection of animals, sampling procedures and
microbiological methods for trials in vivo
For the trials in vivo, live teats rather than excised teats
were used to mimic field conditions, as the Bac+ fer-
mentate, and the challenge pathogens may be affected
by the changing temperatures of the teat surface after
milking (Isaksson & Lind, 1994) or by other conditions
found on live teats, which can be overlooked using an
excised teat model. Eighteen teats of eight lactating
Holstein-Friesian cows were used for the teat dip trials. Of
these, five teats were assigned to the trial with the sta-
phylococcal challenge. Seven teats and a further six teats
were assigned to the trials with Str. dysgalactiae M and
Str. uberis Diernhofer 1932, respectively. One teat in each
of the three trials served as an undipped control. To
identify teats suitable for the experiments, quarter milk
samples of cows were collected aseptically from all trial
cows before the morning (AM) milking. For the latter
sample collection, teats were cleaned by washing with
water and then dried with service-paper towels.
Immediately before sampling, teats were then disinfected
with cotton wool swabs containing Methylated Spirits
(Blackhall Pharmaceutical Distributors Ltd., Swords, Co.
Dublin, Ireland). Twenty-five ml of milk were collected
from each quarter. SCC of milk samples was determined
using the Somacount 300 (Bentley Instruments
Incorporated, USA). Pathogens in milk samples were de-
tected by plating 10 ml of each sample on ABA and in-
cubating overnight at 37 8C. As only teats of healthy
quarters were used for the live challenge trials, teats were
enrolled if quarter milk samples taken before the trial had
a SCC of <400r103 cells/ml and were free of pathogens.
Additionally, the selected teats were free from warts, le-
sions, crusts or abrasions, showed a uniform size, with
smooth teat skin and no signs of inflammation (redness,
tenderness or swelling).
Challenge, teat dipping procedure and recovery of
challenge bacteria used in trials in vivo
Following the AM milking, the selected teats and the sur-
rounding skin were prepared for the trial by washing
with lukewarm water. Teats and udder were subsequently
dried with service paper towels. Washed teats were then
disinfected twice from teat base to tip with cotton
wool swabs containing Methylated Spirits (Blackhall
Pharmaceutical Distributors Ltd). The challenge and teat
dipping procedures were essentially a modified version
of the procedure described by Philpot et al. 1978. The
principal dipping technique is shown in Fig. 1. In brief, the
washed and disinfected teats (including control teats) were
dipped once in 25-ml beakers containing 12-ml volumes
of the challenge culture. The teat tip had to touch the
bottom of the beaker to ensure equal coating of each teat
with the challenge organism. Following a 5-min drainage
time, each of the teats selected for dipping with the DPC
3251 teat dip was submerged into a beaker containing
20 ml of the experimental dip, while one teat per organism
type remained undipped as a negative control. The contact
time for the teat dip was 10 min. Following the contact of
the challenge organisms with the dip, the surviving or-
ganisms were recovered by submerging the teats (control
and dipped teats) into sterile beakers containing 20 ml
MRD (Maximum Recovery Diluent, Oxoid Ltd.,
Hampshire, England). The final recovery suspension from
each teat was then stored in Sterilin bottles and immedi-
ately transported to the laboratory to enumerate the sur-
viving bacterial cells. The recovery solutions were diluted
and plated in duplicate within 2 h of collection. Plates
were incubated overnight at 37 8C and viable challenge
pathogens were counted.
Aftercare of the animals
To remove any remaining bacteria from the teat surface,
all teats were disinfected with cotton wool swabs soaked
in Methylated Spirits after the final recoveries were taken.
The teats were then washed with lukewarm water to re-
move any teat-dip residues. Teats were subsequently dried
with service paper towels. Finally, the teats were sprayed
with a commercial teat dip, Deosan Summer Teatcare
Plus (RTU, Diversey Lever) which was used routinely in
the herd.
Results
Preparation of the fermented teat dip and lacticin content
throughout storage
Teat dips used in all the experiments consisted of the de-
scribed fermentate of Lc. lactis DPC 3251 grown in 10%
RSM (Bac+ fermentate). Generally, teat dips produced by
growing Lc. lactis DPC 3251 contained bacterial counts
1.  Teats coated with the 3251 teat dip
     subsequent to challenge
2.  Teats in preparation for recovery
     of viable pathogens with 20 mls of 
     MRD solution
3.  Teat submerged in MRD solution
     for recovery of pathogens
3.
1.
2.
Fig. 1. Technique for challenge, teat dip, wash off and recovery
on live teats
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of 109 cfu/ml after 20-h incubation at 30 8C. The lacticin
activity for each Bac+ fermentate used in bactericidal
assays or live teat challenges was o10 240 AU/ml at a pH
value of approx. 4.4. No lacticin activity was detected
in Bac– fermentates and the pH value of the control
fermentates was always similar to that of the lacticin-
containing fermentate at approx. 4.4.
The lacticin stability of two dips was assessed during
storage of the dip at 4 8C for up to 21 d. The mean lacticin
activity in the dips declined to 60% in the first 7 d of sto-
rage (Fig. 2) but the bacteriocin still retained 53% of its
activity until the final sampling day.
Bactericidal assays against Gram-positive mastitis
pathogens
The anti-bacterial efficacy of the fermented teat dip was
first evaluated ex vivo against Staph. aureus DPC 5246,
Str. dysgalactiae M and Str. uberis Diernhofer 1932.
A control fermentate produced by the Bac– strain Lc. lactis
DPC 5399 was included in the assays. When exposed to
the Bac+ fermentate, Staph. aureus DPC 5246 was rapidly
killed and no live cells were recovered after 30 min of in-
cubation (a reduction of 5.2 log10 cfu/ml). In contrast, the
Bac– fermentate resulted in a decrease in viability of
only 1.6 log10 cfu/ml (Fig. 3). The Bac
+ fermentate there-
fore resulted in a reduction of staphylococci of 3.6
log10 cfu/ml compared with the Bac
– fermentate.
Similarly, when Str. dysgalactiae M was incubated with
the Bac+ teat dip, no viable pathogens could be detected
after 15 min (a reduction of at least 5 log10 cfu/ml; Fig. 3).
Given that the Bac– fermentate resulted in a reduction of
only 0.7 log10 cfu/ml we conclude that the majority of the
bactericidal action of the dip is due to the lacticin content.
In contrast, Str. uberis Diernhofer 1932 seemed to survive
better in the Bac+ dip, where numbers were reduced by
approximately 2 log10 cfu/ml in the first 15 min (T0–T15).
After 120 min some live cells were still present albeit at
a very low numbers (approx. 60 cfu/ml). Again, Str. uberis
Diernhofer 1932 was only slightly reduced in the Bac–
control solution (Fig. 3).
Efficacy of the lacticin-based teat dip in vivo
To evaluate the potential value of performing large scale
animal trials, we examined the short-term effect of the
Bac+ fermentate on live teats of lactating dairy cows.
For this purpose three separate, small scale teat dip trials
were performed in which five teats were challenged with
staphylococci, seven with Str. dysgalactiae and a further
six with Str. uberis. To gain sufficient bacterial recoveries
for monitoring purposes, challenge concentrations for
these trials were set greater than 107 cfu/ml. When Staph.
aureus DPC 5246 was used as the challenge organism,
mean recoveries of viable staphylococci on the teats dip-
ped with the DPC 3251 dip were 4.68 log10 cfu/ml.
Compared with the recoveries from the untreated control
teat, this represented an 80±8% elimination of the chal-
lenge organism on the teat surface (Fig. 4). The mean
streptococcal recovery after dipping with the DPC 3251
teat dip was 2.68 log10 cfu/ml for Str. dysgalactiae M
and the mean elimination was found to be 97.5±2.5%
(Fig. 4). Mean recoveries from teats challenged with
Str. uberis Diernhofer 1932 were 3.8 log10 cfu/ml, re-
presenting an elimination of 90.2±5.3% (Fig. 4). No ani-
mal or quarter enrolled showed any signs of infection with
the pathogens used for the challenge procedure after the
trial.
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Fig. 2. Mean percentage of lacticin activities of two Lacto-
coccus lactis DPC 3251 fermentates over a storage period of
3 weeks at 4 8C. Errors indicate ±1SD.
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Fig. 3. Bactericidal efficacy of the fermentate of Lactococcus
lactis DPC 3251 (black squares, &) and a Bac– fermentate as a
control (white squares, %) on Staphylococcus aureus DPC 5246
(A), Streptococcus dysgalactiae M (B) and Streptococcus uberis
Diernhofer 1932AL (C). Errors indicate ±1SD
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Discussion
The use of teat dips is considered to be an essential el-
ement of on-farm practice and contributes to both good
milk quality and improved animal health. However, most
dips are based on disinfectants of a synthetic nature, which
can lead to residues in milk. Such residues may lead to
quality problems in later processing such as the presence
of high amounts of iodine in infant formula as discussed by
Fisher (1989). Only a few studies have addressed the ap-
plication of more natural products with antimicrobial
properties for use as teat dips (Oliver & Mitchell, 1985;
Sears et al. 1992; Koskinen et al. 1996; Serieys & Poutrel,
1996; Leon et al. 2004).
In the present study, we generated a fermented teat dip
containing a bacteriocin-producing live culture and eval-
uated its efficacy at killing mastitic pathogens. Importantly,
the resultant dip was shown to be highly effective in killing
both Staph. aureus and Str. dysgalactiae as well as reduc-
ing numbers of Str. uberis by approx. 3 log10 cfu/ml (Fig. 3).
The effects observed in vitro were more than likely due
to the bacteriocin lacticin, since initial controls using
acidified RSM (data not shown) and controls using the
Bac– fermentate demonstrated that neither acid nor a non-
producing strain could result in the reduction of >1
log10 cfu/ml for acidified 10% RSM (data not shown) or
>1.6 log10 cfu/ml for the Bac
– fermentate in a staphylo-
coccal challenge (Fig. 3). The incomplete elimination of
Str. uberis by the Bac+ fermentate in the experiments ex
vivo might have been due to its slower growth rates in
milk. Indeed, we have previously shown that the lacticin
peptides have a dual mechanism involving both cell wall
inhibition (binding to lipid II) and pore formation, the latter
of which is associated with the energy state of the cell
(McAuliffe et al. 1998; Wiedemann et al. 2006). It has
been shown previously that the specific udder pathogens
Staph. aureus and Str. dysgalactiae are highly adapted to a
milk-based environment and therefore growth rates of
these two mastitis pathogens in milk can be higher than
growth rates of the environmental pathogen Str. uberis
(Oz et al. 1986). Thus, as lacticin activity depends on the
energy status of the target cell, this may explain why
Staph. aureus and Str. dysgalactiae are killed more effec-
tively than the slow-growing Str. uberis in the milk-based
environment of the fermented dip. A longer incubation
period might have resulted in a more complete elimination
of Str. uberis. However, as Staph. aureus is the most fre-
quently isolated strain in Irish dairy cows with high SCC
(Barrett et al. 2005) we want to emphasize that the effects
of the teat dip resulted in a complete elimination of Staph.
aureus.
Teat dips containing nisin have been investigated pre-
viously (Sears et al. 1992; Serieys & Poutrel, 1996).
Lacticin, however, has an advantage over nisin for such
applications as it is more active at physiological pH.
Indeed, we have previously shown that nisin was unable
to inhibit the growth of Str. dysgalactiae at neutral pH
when incorporated into a teat seal formulation, whereas
lacticin was able to show a clear zone of inhibition (Ryan
et al. 1998). Similarly, nisin was unable to reduce numbers
of staphylococci in skim milk at neutral pH only showing
best effects against Staph. aureus under low-pH conditions
(Sobrino-Lopez & Martin-Belloso, 2006). These results
might suggest that a lacticin-based teat dip would be more
effective on the teat surface than a similarly manufactured
nisin-based dip, although this would need to be tested
experimentally.
In a study by Oliver & Mitchell (1985), a natural prep-
aration made from Lactobacillus acidophilus reduced
numbers of Gram-positive mastitis pathogens on chal-
lenged teats when compared with an iodine solution. On
excised teats, the Lb. acidophilus preparation reduced
levels of Staph. aureus and streptococcal species by 72%
and >95%, respectively. These numbers are comparable
to the efficacy of the 3251 fermentate in the present study,
as staphylococci were reduced by approx. 80% and aver-
age streptococcal reductions were approx. 96%. Sears
et al. (1992) found that purified nisin reduced Staph. aur-
eus on the teat skin of live cows by 3.9 log10 cfu/ml after
an exposure of 1 min compared with a reduction of 0.7
log10 cfu/ml for staphylococci in the present study after a
contact time of 10 min. It should be emphasised, however,
that a preparation based on purified or highly concentrated
nisin may prove expensive for such applications.
Additionally, it should be noted that as Staph. aureus
strains can vary significantly in virulence potential
(Dingwell et al. 2006) and indeed in susceptibility to lac-
ticin 3147 itself (Ryan et al. 1998), our results cannot be
compared directly with the results with nisin as different
isolates of Staph. aureus were used.
Another factor which should be considered in the
analysis of our results is the absence of any surfactants or
emollients in the dips described in this study. Surfactants
and emollients are used in commercial teat disinfectants
in order to ensure proper coating of the teat surface and
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Fig. 4. Mean percent elimination of Staphylococcus aureus
DPC 5246 (four teats), Streptococcus dysgalactiae M (six teats)
and Streptococcus uberis Diernhofer 1932 (five teats) on teats of
cows dipped with 3251 teat dip compared to one undipped
control teat each. Errors indicate ±1SD
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to keep the teat skin smooth and moisturized. One such
surfactant and one emollient have been integrated into the
3251 dip in other assays. Addition of the surfactant
Texapon (TEA Lauryl Sulphate, courtesy of Cross Vet,
Research Laboratories, Ireland) at a concentration of 1%
(v/v) or the emollient Glycerol (Sigma Aldrich Ireland
Ltd., Dublin, Ireland) at a concentration of 5% (v/v) to the
lacticin teat dip did not increase the average antibacterial
effectiveness in these assays when compared with results
of the teat dip without additives (data not shown).
However, more studies should be undertaken to determine
whether other surfactants could enhance the activity of the
lacticin-based dip.
It was previously found that under varying natural con-
ditions streptococcal and staphylococcal counts on teats
never exceeded approx. 3 or 4 log10 cfu/ml respectively
(Hogan et al. 1990). Therefore, artificial teat challenge
models present a much higher bacterial count to any ex-
perimental teat dip than in conditions found under natural
exposure. Therefore under natural conditions, the dip may
be even more effective. Another parameter which may
have influenced the results of the activity of the dips was
the incubation temperature of 37 8C used when recovering
pathogens. Although the resting skin surface temperature
of the teat in a housed cow averages 30 8C, it has been
shown that during milking, the temperature of the teat
surface can be subject to change and can range from 29 8C
to 38 8C (Isaksson & Lind, 1994). The surface temperature
is also higher after milking when the milk flow has
warmed the teat surface (Isaksson & Lind, 1994).
Therefore, as teat dips are applied immediately post milk-
ing, when the milk flow has warmed the teat surface, it
was decided that similarly to Koskinen et al. (1996), for the
bactericidal assays in vitro, an incubation temperature
of 37 8C should be used. This may also have positively
selected for pathogens as this temperature is rec-
ommended by National Mastitis Council for optimal re-
covery of pathogens and is also substantially higher than
the optimum growth temperature for Lc. lactis DPC 3251
of 30 8C (S Morgan, personal communication). To examine
the 3251 dip on a larger scale, a natural exposure trial,
also evaluating the effectiveness of the dip at varying
temperatures, would therefore be recommended. In the
natural exposure trial by Koskinen et al. (1996) fewer iso-
lates of Staph. aureus (2.09%) or coagulase-negative sta-
phylococci (2.52%) were found in milk from udder
quarters dipped with sour milk compared with the results
of undipped controls (3.09% and 4.07% of total isolates,
respectively). The group dipped with an iodine-containing
dip had the least number of Staph. aureus isolates (0.83%
total isolates) ; however, there were no statistical signifi-
cant differences between treatments. Following their
natural exposure trial, Oliver & Mitchell (1985) concluded
that their Lb. acidophilus preparation was effective in
preventing intramammary infections by 57% when com-
pared with the number of infections in the undipped con-
trol group. Additionally, no teat irritations were noticed. In
a field trial evaluation by Se´rieys & Poutrel (1996) a com-
mercial dip formulation containing nisin was compared
with a 0.5% iodine dip. No significant difference in new
infection rates was found. Another non-chemical teat dip
based on an Aloe Vera gel was also compared with an
iodine dip in a field trial. Results showed that the mastitis
occurrence in both groups was not significantly different
(Leon et al. 2004). These results have therefore shown that
to date, alternative (‘non-chemical’) teat dips have proven
efficient in preventing mastitis.
From a food perspective, consumers are becoming more
aware of the sources, contents and the production of food,
which is evident from the rising demands for organic and
natural dairy products (McElroy, 2008). In this respect, a
natural, non-chemical teat dip containing food grade bac-
teria would certainly be of benefit for the dairy industry.
Additionally, given that chemical teat dips can cause se-
vere irritation of the skin (Sears et al. 1992), the search for
milder agents with antimicrobial action seems to be a
sensible approach. In the present study, the teat skin effect
of an application of the 3251 dip was not examined,
though in the long term trials by Koskinen et al. (1996) and
Oliver & Mitchell (1985) using similar products, no ad-
verse effects on the teat skin with either teat dip were
mentioned.
If teat dips containing food grade bacteria were to be
commercialized, problems with increases in total bacteria
count (TBC) might arise as levels of, in this case, Lc. lactis
DPC 3251 in the milk might lead to a rise in the resulting
bacterial count. Dairy co-operatives, however, could use
differential counting of TBC for dairy farms using such a
teat dip. The effect of milk containing LAB on processing
would also require investigation, though the process of
pasteurization, which would eliminate any remaining lac-
tococci, is used in most dairy processing plants and raw
milks are rarely used.
In conclusion, the lacticin-containing 3251 teat dip used in
this study decreased Gram-positive mastitis pathogens under
laboratory conditions as well as on the teats of live cows. Further
investigations in accordance with National Mastitis Council re-
commendations (Nickerson et al. 2004) would be required in
order to produce a commercially viable product.
References
Arbesman H 2005 Dairy and acne-the iodine connection. Journal of the
American Academy of Dermatology 53 1102
Barrett DJ, Healy AM, Leonard FC & Doherty ML 2005 Prevalence of
pathogens causing subclinical mastitis in 15 dairy herds in the
Republic of Ireland. Irish Veterinary Journal 58 333–337
Bennett R, Christiansen K & Clifton-Hadley R 1999 Preliminary estimates
of the direct costs associated with endemic diseases of livestock in
Great Britain. Preventive Veterinary Medicine 39 155–171
Crispie F, Alonso-Gomez M, O’Loughlin C, Klostermann K, Flynn J,
Arkins S, Meaney W, Ross RP & Hill C 2008 Intramammary infusion of
a live culture for treatment of bovine mastitis : effect of live lactococci
on the mammary immune response. Journal of Dairy Research 75
374–384
Lacticin-based teat dip 237
Crispie F, Twomey D, Flynn J, Hill C, Ross P & Meaney W 2005
The lantibiotic lacticin 3147 produced in a milk-based medium im-
proves the efficacy of a bismuth-based teat seal in cattle deliberately
infected with Staphylococcus aureus. Journal of Dairy Research
72 159–167
Danby FW 2007 Acne and iodine: reply. Journal of the American
Academy of Dermatology 56 164–165
Dingwell RT, Leslie KE, Sabour P, Lepp D & Pacan J 2006 Influence of the
genotype of Staphylococcus aureus, determined by pulsed-field gel
electrophoresis, on dry-period elimination of subclinical mastitis in
Canadian dairy herds. Canadian Journal of Veterinary Research 70
115–120
Fisher DA 1989 Upper limit of iodine in infant formulas. Journal of
Nutrition 119 1865–1868
Galton DM, Petersson LG & Erb HN 1986 Milk iodine residues in herds
practicing iodophor premilking teat disinfection. Journal of Dairy
Science 69 267–271
Halasa T, Huijps K, Østera˚s O & Hogeveen H 2007 Economic effects of
bovine mastitis and mastitis management: a review. Veterinary
Quarterly 29 18–31
Hogan JS, Smith KL, Todhunter DA & Schoenberger PS 1990 Bacterial
counts associated with recycled newspaper bedding. Journal of Dairy
Science 73 1756–1761
International Dairy Federation 1981 Chapter 3: Isolation and identifi-
cation of mastitis bacteria. In : Laboratory methods for use in mastitis
work, Bulletin 132 19–26
Isaksson A & Lind O 1994 Brief Communication: Milking-related changes
in the surface temperature of the bovine teat skin. Acta Veterinaria
Scandinavica 35 435–438
Klostermann K, Crispie F, Flynn J, Ross RP, Hill C & Meaney W 2008
Intramammary infusion of a live culture of Lactococcus lactis for
treatment of bovine mastitis : comparison with antibiotic treatment in
field trials. Journal of Dairy Research 75 365–373
Koskinen E, Rantala M & Saloniemi H 1996 The effect of sour milk as a
postmilking teat dip for mastitis prevention in a dairy herd. Acta
Veterinaria Scandinavica 37 427–432
Leon L, Beer C, Wacken H, Nurnberg M & Andersson R 2004 [Effect on
teat skin condition and effectivity against new intramammary infec-
tions of a barrier teat dip based on aloe vera gel.] Tiera¨rztliche
Umschau 59 237–244
Losinger WC 2005 Economic impacts of reduced milk production as-
sociated with an increase in bulk-tank somatic cell count on US
dairies. Journal of the American Veterinary Medical Association 226
1652–1658
McAuliffe O, Ryan MP, Ross RP, Hill C, Breeuwer P & Abee T 1998
Lacticin 3147, a broad-spectrum bacteriocin which selectively dis-
sipates the membrane potential. Applied and Environmental Micro-
biology 64 439–445
McElroy B 2008 Global statistics of the organic market. Ecological
Farming Conference, Pacific Grove CA, USA.
Nickerson SC, Saxon A, Fox LK, Hemling T, Hogan JS, Morelli J,
Oliver SP, Owens WE, Pawlak M & Petersson L 2004 National
Mastitis Council : Recommended protocols for evaluating efficacy of
postmilking teat germicides. In: NMC Annual Meeting Proceedings
pp. 379–399
Oliver SP & Mitchell BA 1985 Prevention of bovine mastitis by a
Lactobacillus acidophilus preparation. Journal of Dairy Science 68
271
Oz HH, Farnsworth RJ & Cox HU 1986 Growth of Gram-positive mas-
togenic bacteria in normal, simulated bulk tank, and mastitic milk held
at simulated fluctuating temperatures of farm bulk tank. Journal of
Dairy Science 69 2060–2065
Pankey JW, Eberhart RJ, Cuming AL, Daggett RD, Farnsworth RJ &
McDuff CK 1984 Uptake on postmilking teat antisepsis. Journal of
Dairy Science 67 1336–1353
Park YK, Harland BF, Vanderveen JE, Shank FR & Prosky L 1981
Estimation of dietary iodine intake of Americans in recent years.
Journal of the American Dietetic Association 79 17–24
Pennington JA, Young BE & Wilson DB 1989 Nutritional elements in
US diets : results from the Total Diet Study, 1982–1986. Journal of the
American Dietetic Association 89 659–664
Persson Waller K, Bengtsson B, Lindberg A, Nyman A & Ericsson H 2009
Incidence of mastitis and bacterial findings at clinical mastitis in
Swedish primiparous cows—influence of breed and stage of lactation.
Veterinary Microbiology 134 89–94
Philpot WN, Boddie RL & Pankey JW 1978 Hygiene in the prevention of
udder infections. IV. Evaluation of teat dips with excised cows’ teats.
Journal of Dairy Science 61 950–955
Rea MC & Cogan TC 1994 Buttermilk plants : the Irish version of kefir.
Irish Scientist 2 7
Ryan MP, Rea MC, Hill C & Ross RP 1996 An application in cheddar
cheese manufacture for a strain of Lactococcus lactis producing a
novel broad-spectrum bacteriocin, lacticin 3147. Applied and En-
vironmental Microbiology 62 612–619
Ryan MP, Meaney WJ, Ross RP & Hill C 1998 Evaluation of lacticin 3147
and a teat seal containing this bacteriocin for inhibition of mastitis
pathogens. Applied and Environmental Microbiology 64 2287–2290
Ryan MP, Flynn J, Hill C, Ross RP & Meaney WJ 1999 The natural food
grade inhibitor, lacticin 3147, reduced the incidence of mastitis after
experimental challenge with Streptococcus dysgalactiae in nonlactat-
ing dairy cows. Journal of Dairy Science 82 2625–2631
Sears PM, Smith BS, Stewart WK, Gonzalez RN, Rubino SD, Gusik SA,
Kulisek ES, Projan SJ & Blackburn P 1992 Evaluation of a nisin-based
germicidal formulation on teat skin of live cows. Journal of Dairy
Science 75 3185–3190
Serieys F & Poutrel B 1996 Field trial evaluation of two teat dips con-
taining nisin or polyvinylpyrrolidone iodophor designed for use before
and after milking. Veterinary Research 27 295–303
Sit CS & Vederas JC 2008 Minireview: Approaches to the discovery of
new antibacterial agents based on bacteriocins. Biochemistry and Cell
Biology 86 116–123
Sobrino-Lopez A & Martin-Belloso O 2006 Enhancing inactivation of
Staphylococcus aureus in skim milk by combining high-intensity
pulsed electric fields and nisin. Journal of Food Protection 69 345–353
Twomey DP, Wheelock AI, Flynn J, Meaney WJ, Hill C & Ross RP 2000
Protection against Staphylococcus aureus mastitis in dairy cows using
a bismuth-based teat seal containing the bacteriocin, lacticin 3147.
Journal of Dairy Science 83 1981–1988
Vanderveen JE 1979 Estimation of total iodine consumption by Americans
in recent years. Presented at: Iodine Workshop, American Medical
Association, Scottsdale, Arizona, November 13–14
Wiedemann I, Bottiger T, Bonelli RR, Wiese A, Hagge SO, Gutsmann T,
Seydel U, Deegan L, Hill C, Ross RP & Sahl HG 2006 The mode of
action of the lantibiotic lacticin 3147-a complex mechanism involving
specific interaction of two peptides and the cell wall precursor lipid II.
Molecular Microbiology 61 285–296
Whist AC, Østera˚s O & Solverod L 2007 Staphylococcus aureus and
Streptococcus dysgalactiae in Norwegian herds after introduction of
selective dry cow therapy and teat dipping. Journal of Dairy Research
74 1–8
Yalcin C, Stott AW, Logue DN & Gunn J 1999 The economic impact
of mastitis-control procedures used in Scottish dairy herds with high
bulk-tank somatic-cell counts. Preventative Veterinary Medicine 41
135–149
238 K Klostermann and others
